Trump's sons say his new phone will be built in the US. Experts say it looks a lot like a phone from China
When the Trump Organization unveiled its new Trump Mobile wireless service on Monday, it said its upcoming T1 smartphone will be 'proudly designed and built in the United States.'
But experts told CNN they're skeptical that a smartphone can be built in the US based on the specifications, price and timeline laid out by Donald Trump, Jr., and Eric Trump, when they announced the phone.
Experts pointed out striking similarities between the T1's specifications and an already available, Chinese-made phone.
'Unless the Trump family secretly built out a secure, onshore or nearshore (fabrication) operation over years of work without anyone noticing, it's simply not possible to deliver what they're promising,' said Todd Weaver, CEO of Purism, one of the only known companies to actually manufacture a cell phone in the United States.
CNN has reached out to the Trump Organization for comment.
President Donald Trump is not involved in the daily operations of the Trump Organization, which is run by the president's eldest sons, the company said in January. The announcement comes as the president has been pushing to bring manufacturing jobs back to the United States, particularly in the tech industry. He's pressured companies like Apple and Samsung to manufacture their phones in the US, saying companies who make their phones elsewhere will face a tariff of at least 25%.
The Trump family say on Trump Mobile's website and in the formal announcement in Trump Tower on Monday that the phone will be 'Made in the USA.' But later, in a clip from an interview with conservative media personality Benny Johnson, Eric Trump said 'eventually all the phones can be built in the United States of America.' CNN has asked the Trump Organization whether the T1 phone will initially be built in the US.
Both Weaver and a second expert, Max Weinbach, an analyst at market research firm Creative Strategies, independently told CNN they believe the T1 phone looks like a version of the already available Revvl 7 Pro 5G, made by China-based Wingtech, which provides manufacturing services for smartphones and other products. The phone retails for around $169 on Amazon.
Weinbach and Weaver base this off the specifications listed by Trump Mobile, including the phone's body, battery and camera resolution. There's no direct evidence linking Trump's phone directly to the Revvl 7 Pro 5G or any specific phone made outside the US. CNN has reached out to Wingtech for comment.
'There (are) only realistically four or five smartphone ODM (original device manufacturers) that would actually be able to manufacture something like this,' Weinbach said. 'All of them are based out of China.'
The Revvl device has the same screen size, battery capacity and storage as the T1 phone according to the information listed on the Trump Mobile website , and both phones have a headphone jack – a rare find on modern smartphones. However, the Revvl's camera is slightly different, and the T1 phone has more memory. Revvl's camera is slightly different, and the T1 phone has more memory.
Another device labeled the Vtex Smart Phone listed on Made-in-China, a website for connecting buyers with Chinese suppliers, has specifications that are nearly identical to the T1's – including the same battery capacity, camera arrangement and supported software version, although it's unclear if the device has a headphone jack, and there are some differences in the memory and display. CNN has reached out to Shenzen Vitek Electronics Co., the company behind the Vtex Smart Phone, for comment.
Weinbach says it's common for companies to customize devices made by ODMs before selling them under their own brand.
'A lot of them share the same components, parts, boards and antenna hardware,' he said. 'So, you can swap out a couple of things.'
In a press release, the Trump Organization said Trump Mobile's products are not 'designed, developed, manufactured, distributed or sold by The Trump Organization or any of their respective affiliates or principals.'
Building a phone in the US would be challenging, if not impossible, for a September 2025 launch in part because the US doesn't currently have the necessary fabrication plants, said Ryan Reith, Group Vice President for the International Data Corporation's Worldwide Device Tracker. And many of the components would likely still come from overseas.
'Any phone (that) is going to be sold in September, or shipped in September into the US, the majority of it's not going to be manufactured in the US,' said Reith. 'That's a given.'
For example, Trump has pushed for months for Apple to build its signature product, the iPhone, in the United States. But that would mean a massive supply chain shift away from China and India. Nor would it mean just a change in factory resources – those countries also have highly specialized work forces that the US lacks. The result could mean price hikes or design changes for the iPhone, some analysts estimate.
Weaver told CNN that sometime within the last year intermediaries working with the Trump Organization had been looking at Purism's phone and speaking to the company about what it takes to make a phone in the United States.
Purism makes the $1,999 Liberty Phone, which touts itself as a secure 'Made in America' phone, although even they are forced to source some parts from abroad.
'There are certain areas where you're going to still need to have a global supply chain. One example is a crystal that goes in our GNSS chip or GPS chip. That single crystal is only manufactured in China,' Weaver said.
Weaver pointed out the Federal Trade Commission has 'strict guidelines' on claiming an item is 'Made in the USA.'
'I do believe there will be a massive amount of back pedaling that goes on,' Weaver said. 'Just to manufacture a phone in the US with the chip sets you're actually getting, purchase and support with the US supply chain is a massive undertaking, and that's also the reason why we happen to be the only ones doing it.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech
Eli Lilly has been in the spotlight recently with a 3.96% share price increase over the past month. The selection of RyboDyn Inc. to join Lilly Gateway Labs stands out among recent developments, signaling strengthened research capabilities in precision immunotherapies and potentially bolstering investor confidence. Additionally, the company's legal entanglement with the lawsuit concerning Actos, following a class certification affirmation, highlights ongoing challenges in the pharmaceutical sector. The company's ongoing talks to acquire Verve Therapeutics also show its commitment to growing its gene-editing capabilities. These events have added weight to the broader market's trends. We've identified 2 warning signs for Eli Lilly (1 can't be ignored) that you should be aware of. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. Recent developments at Eli Lilly, such as the RyboDyn Inc. collaboration, have potential implications for its strategic growth, particularly in precision immunotherapies. This aligns with the company's narrative of expanding capabilities in oncology and immunology, indicating possible enhancements in revenue and earnings forecasts over the long term. Additionally, as Eli Lilly progresses with Phase III trials, including those for orforglipron, the anticipated product approvals could bolster revenue avenues by tapping into high-demand markets like diabetes and obesity treatments. Over the past five years, Eli Lilly's total shareholder return was a very large 430.14%, demonstrating substantial long-term growth despite recent underperformance against the US Pharmaceuticals industry, which saw a 8.9% drop over the past year. This impressive five-year return provides context to the company's current position, underscoring a history of robust shareholder value creation. Given the ongoing acquisition talks with Verve Therapeutics and Eli Lilly's significant investment in both manufacturing and R&D, the outlook for future revenue and earnings remains optimistic. However, potential regulatory hurdles and pricing pressures, particularly in the U.S. market, highlight possible challenges. The shares, with a current price of US$775.12, are 21.0% below the analyst consensus target of US$981.63. This discount suggests room for growth, should the company meet or exceed the analyst expectations on revenue and earnings. Learn about Eli Lilly's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:LLY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
40 minutes ago
- Yahoo
Stellantis Evaluates Maserati's Future, Including Potential Sale -- Reuters
Stellantis (STLA, Financials) is weighing a possible sale of its luxury brand Maserati as part of a broader strategic review, according to a Reuters report citing two unnamed sources familiar with the matter. Warning! GuruFocus has detected 11 Warning Signs with STLA. The discussions reportedly began before newly appointed CEO Antonio Filosa officially takes the helm. Maserati's future is under review as Stellantis navigates a shrinking U.S. market, Chinese competition, and steep tariffs imposed by President Donald Trump on foreign-made cars and parts. Despite the internal review, a Stellantis spokesperson told Reuters that Maserati is not for sale. McKinsey declined to comment. Maserati's sales fell by over 50% last year to 11,300 units, with no new models currently scheduled for launch. A new business plan is expected once Filosa begins his tenure. Stellantis' board remains split on the brand's futuresome directors reportedly view Maserati as a reputational asset, while others believe it lacks viability for a sustainable relaunch. Analysts say streamlining Stellantis' 14-brand portfolio could improve profit margins. The company's shares have lost roughly two-thirds of their value since March 2024. Chinese automakers such as Chery could emerge as potential buyers, echoing earlier moves like Geely's acquisition of Volvo or SAIC's purchase of MG. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
How Advisors Can Avoid Becoming Over-Reliant on AI
Apparently there's no AI in team. Artificial intelligence is being hailed as a key element of the fourth industrial revolution, and new tools are now assisting financial advisors with taking notes, drafting emails, and brainstorming thought leadership content. In fact, the vast majority of advisors said generative AI helped their practices, according to a survey earlier this year. But AI isn't a silver bullet. It lacks emotional intelligence and a human touch. Advisors risk damaging client relationships if they become too reliant on automation — even for routine tasks. 'AI is poor at empathy so far,' said Adrian Johnstone, CEO of the CRM platform Practifi. 'Advisors need to recognize where the personal connection is most powerful, and use AI to automate and alleviate the lesser functions.' READ ALSO: What the GENIUS Act Means for Stablecoins and Advisors and Why UBS Is the Only Wirehouse to Allow Podcasting Today, most advisors use AI to boost meeting efficiency and streamline workflows. Ideally, this frees up more time to spend with clients, but misusing these tools can backfire. 'The common refrain of disaffected clients is: 'I pay you to understand me, my goals, and my fears, not to outsource me to a machine,'' Johnstone said. Wealth management is built on bespoke service, but AI hasn't yet learned to fully adapt to individual client needs and goals. While tools that draft emails and website content are improving, the output still reads 'hollow and generic,' Johnstone warned. Use it or Lose it. Client-facing AI tools can be 'extremely risky' because they can't interpret emotional undertones of client's concerns, said Rafael Loureiro, CEO of an estate planning platform. Still, AI can be useful for quick, factual tasks. 'If it's midnight on a Sunday and a client asks, 'What was my marginal tax rate last year?' that's a perfect use case,' Loureiro said. 'It's not doing financial planning, but answering factual questions.' Everything in Moderation. This isn't the first time new tech or strategies meant to disrupt the wealth management industry have wound up causing trouble for advisors and their clients. Will Trout, director at Datos Insights, pointed to the 2008 financial crisis as a warning. 'Firms that over-relied on risk models without human oversight suffered catastrophic losses,' he told Advisor Upside. This post first appeared on The Daily Upside. To receive financial advisor news, market insights, and practice management essentials, subscribe to our free Advisor Upside newsletter. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
